Jacobs Levy Equity Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Jacobs Levy Equity Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-30,739	Closed	-$184K	–	1150
2016 Q2	$184K	Buy	30,739 +2,900	+10%	+$16.1K	﹤0.01%	1019
2016 Q1	$127K	Buy	+27,839	New	+$124K	﹤0.01%	1015
2014 Q4	–	Sell	-41,988	Closed	-$216K	–	930
2014 Q3	$216K	Buy	41,988 +13,600	+48%	+$72.6K	﹤0.01%	732
2014 Q2	$149K	Buy	28,388 +12,788	+82%	+$55.3K	﹤0.01%	777
2014 Q1	$65K	Sell	15,600 -1,000	-6%	-$3.43K	﹤0.01%	865
2013 Q4	$48K	Sell	16,600 -8,700	-34%	-$21.6K	﹤0.01%	927
2013 Q3	$64K	Sell	25,300 -2,100	-8%	-$4.98K	﹤0.01%	907
2013 Q2	$57K	Buy	+27,400	New	+$60.5K	﹤0.01%	952

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Jacobs Levy Equity Management's ENZ Position: Q3 2016 in Review

Jacobs Levy Equity Management sold out of Enzo Biochem, Inc. (ENZ) in Q3 2016, closing a stake of 30,739 shares — an estimated $184K sold.

Jacobs Levy Equity Management first reported a position in ENZ in Q2 2013 and held it in 8 quarters. The position peaked at $216K in Q3 2014. 111 funds tracked by Wall St. Rank hold ENZ as of Q3 2016.

Jacobs Levy Equity Management reported no remaining Enzo Biochem, Inc. position as of Q3 2016 after selling out during the quarter.
Jacobs Levy Equity Management sold 30,739 Enzo Biochem, Inc. shares in Q3 2016, an estimated $184K.
Jacobs Levy Equity Management first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 8 quarters.
Jacobs Levy Equity Management's Enzo Biochem, Inc. position peaked at $216K in Q3 2014.
111 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2016.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.